ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ACST Acasti Pharma Inc

2.7291
0.0301 (1.12%)
2024年6月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Acasti Pharma Inc ACST NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.0301 1.12% 2.7291 09:00:00
始値 安値 高値 終値 前日終値
2.72 2.61 2.77 2.7291 2.699
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1105:11EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
2024/5/0908:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0908:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0908:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0908:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0908:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1222:00EDGAR2Form 8-K - Current report
2024/2/1221:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/1/0821:30EDGAR2Form 8-K - Current report
2023/12/2106:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1521:30EDGAR2Form 8-K - Current report
2023/11/1321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/2405:30EDGAR2Form 8-K - Current report
2023/10/1705:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/10/1205:30EDGAR2Form 8-K - Current report
2023/10/0705:30EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/9/2808:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2621:10EDGAR2Form 8-K - Current report
2023/9/0604:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2606:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/8/2605:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/8/2605:15EDGAR2Form DEF 14A - Other definitive proxy statements
2023/8/1120:31EDGAR2Form 8-K - Current report
2023/8/1120:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/2506:30EDGAR2Form 8-K - Current report
2023/7/1905:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1905:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1905:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1905:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1905:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1905:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1905:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1022:00PRNUSAcasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON..
2023/7/0721:30EDGAR2Form 8-K - Current report
2023/7/0721:00PRNUSAcasti Pharma Announces 1-for-6 Reverse Stock Split
2023/7/0605:00EDGAR2Form 8-K - Current report
2023/7/0522:00PRNUSAcasti Announces Alignment with FDA on GTX-104 Pivotal Phase..
2023/6/2320:00PRNUSAcasti Pharma Reports Fiscal Year 2023 Operational Results
2023/6/2222:00PRNUSAcasti Announces Appointment of New Scientific Advisory..

最近閲覧した銘柄

Delayed Upgrade Clock